Pharmafile Logo
Pharmafocus logo
Advanced Search

EUSA Pharma bolsters senior leadership team with two appointments

May 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eusa Pharma, appointment

Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two …

Appointment
123_dott_paolo_chiesi_550

Paola Chiesi awarded honorary doctorate by Karolinska Institutet

May 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Paolo Chiesi, Vice President of the Chiesi Group, has been made an Honorary Doctor at the Karolinska Institutet – a …

Appointment
index_ph001

Two Daiichi Sankyo drugs dealt a thumbs up and thumbs down by FDA advisory panel

May 15, 2019
Research and Development, Sales and Marketing Daiichi Sankyo, FDA, pexidartinib, pharma, quizartinib

Daiichi Sankyo was left with a bittersweet taste in its mouth after it saw one of its drugs recommended for …

News

Pfizer & Merck’s Inlyta combo becomes first FDA-approved anti-PD-L1 therapy for kidney cancer

May 15, 2019
Research and Development, Sales and Marketing FDA, Merck KGaA, Pfizer, inylta, pharma, renal cell carcinoma

The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). …

News

NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza

May 15, 2019
Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy

NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …

News
gilead-sciences

Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says

May 15, 2019
Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs

Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …

News
stormotion

Medical Affairs 2025 – Excellence in the era of precision medicine

May 15, 2019
Medical Communications, Research and Development pharma, veeva

Medical affairs is at the leading edge of a trend. As the life sciences industry shifts towards precision medicine, its …

News

Ex-GSK, Novartis exec named as Mundipharma’s Head of Access

May 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma

Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …

Appointment
sleeping-baby-1540295803spt

Prophylactic antibiotic use could halve post-birth maternal infections, study indicates

May 14, 2019
Manufacturing and Production, Research and Development Antibiotics, University of Oxford, pharma

A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all …

News
ipos0_l

FDA expands indication for Eylea to cover all stages of diabetic retinopathy

May 14, 2019
Manufacturing and Production Bayer, Eylea, FDA, Regeneron, approval, pharma

The FDA has expanded the indication for Regeneron’s Eylea (aflibercept) to include all stages of diabetic retinopathy. Regeneron chief scientific …

News
mental-health-3332122_960_720

Mental health spending varies dramatically among regions in England, analysis shows

May 14, 2019
Manufacturing and Production England, NHS, UK, mental health, mind, spending

Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind. South Yorkshire …

News
merck-keytruda

MSD’s Keytruda recommended on NHS in Scotland for Stage 3 melanoma

May 14, 2019
Manufacturing and Production, Sales and Marketing Cancer, MSD, Scotland, Scottish Medicines Consortium, keytruda, melanoma, pharma

MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC) …

News
chinese_flag_beijing_-_img_1104

Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says

May 14, 2019
Manufacturing and Production China, US, USTR, pharma, tariffs, trade

The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …

News
shutterstock_206748499

The interplay between the GDPR and the EU Clinical Trials Regulation

May 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, clinical trial data, clinical trials, eu clinical trials regulation, pharma, trial data

Paul Kavanagh, partner at law firm Dechert, explores the relationship between GDPR and CTR, and its potential impact on the …

Feature
shutterstock_87495637

UK GPs are underequipped to handle growing chronic opioid use, report warns

May 13, 2019
Medical Communications, Sales and Marketing NHS, UK, opioid crisis, opioids, pharma

New research from the University of East Anglia (UEA) has argued that general practitioners (GPs) in the UK are lacking …

News
hepatitis_a_virus_01

US sees 300% increase in the number of cases of Hepatitis A

May 13, 2019
Sales and Marketing CDC, hepatitis a, pharma, public health, sanitation

The number of Americans infected with Hepatitis A has increased 300% in the past three years, according to figures from …

News

Heart disease deaths increase for first time in 50 years

May 13, 2019
Sales and Marketing BHF, UK, cardiovascular, health, heart disease, obesity

Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years. …

News
lilly_entrance_web

Lilly’s Cyramza approved in US for hepatocellular carcinoma sub-population

May 13, 2019
Sales and Marketing Eli Lilly, FDA, cyramza, hepatocellular carcinoma, pharma

Eli Lilly’s vascular endothelial growth factor (VEGF) receptor 2 antagonist Cyramza (ramucirumab) has received approval in the US as a …

News
teva_copy

US States allege 20 generic drugmakers fixed prices of generic drugs

May 13, 2019
Sales and Marketing competition, generics, markets, price fixing, price-fixing, pricing

Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms …

News
fda2outsideweb

FDA to end controversial “alternative summary reporting” of medical devices in bid to boost transparency

May 10, 2019
Medical Communications, Research and Development, Sales and Marketing FDA, US, adverse events, medical devices, pharma

The FDA has revealed that it plans to terminate its “alternative summary reporting” programme which has allowed the manufacturers of …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026